These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
216 related items for PubMed ID: 9466701
21. Low frequency of rearrangements of the ret and trk proto-oncogenes in Japanese thyroid papillary carcinomas. Wajjwalku W, Nakamura S, Hasegawa Y, Miyazaki K, Satoh Y, Funahashi H, Matsuyama M, Takahashi M. Jpn J Cancer Res; 1992 Jul; 83(7):671-5. PubMed ID: 1381340 [Abstract] [Full Text] [Related]
22. High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solid-follicular variant. Thomas GA, Bunnell H, Cook HA, Williams ED, Nerovnya A, Cherstvoy ED, Tronko ND, Bogdanova TI, Chiappetta G, Viglietto G, Pentimalli F, Salvatore G, Fusco A, Santoro M, Vecchio G. J Clin Endocrinol Metab; 1999 Nov; 84(11):4232-8. PubMed ID: 10566678 [Abstract] [Full Text] [Related]
23. RET rearrangements in papillary thyroid carcinomas and adenomas detected by interphase FISH. Cinti R, Yin L, Ilc K, Berger N, Basolo F, Cuccato S, Giannini R, Torre G, Miccoli P, Amati P, Romeo G, Corvi R. Cytogenet Cell Genet; 2000 Nov; 88(1-2):56-61. PubMed ID: 10773666 [Abstract] [Full Text] [Related]
24. Molecular and biochemical analysis of RET/PTC4, a novel oncogenic rearrangement between RET and ELE1 genes, in a post-Chernobyl papillary thyroid cancer. Fugazzola L, Pierotti MA, Vigano E, Pacini F, Vorontsova TV, Bongarzone I. Oncogene; 1996 Sep 05; 13(5):1093-7. PubMed ID: 8806699 [Abstract] [Full Text] [Related]
25. Molecular analysis of new subtypes of ELE/RET rearrangements, their reciprocal transcripts and breakpoints in papillary thyroid carcinomas of children after Chernobyl. Klugbauer S, Demidchik EP, Lengfelder E, Rabes HM. Oncogene; 1998 Feb 05; 16(5):671-5. PubMed ID: 9482114 [Abstract] [Full Text] [Related]
26. [Rearrangement of the RET gene in papillary thyroid carcinoma]. Wiench M, Włoch J, Oczko M, Gubała E, Jarzab B. Wiad Lek; 2001 Feb 05; 54 Suppl 1():64-71. PubMed ID: 12182064 [Abstract] [Full Text] [Related]
27. RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes. Tallini G, Santoro M, Helie M, Carlomagno F, Salvatore G, Chiappetta G, Carcangiu ML, Fusco A. Clin Cancer Res; 1998 Feb 05; 4(2):287-94. PubMed ID: 9516913 [Abstract] [Full Text] [Related]
28. [Molecular analysis of structural abnormalities in papillary thyroid carcinoma gene]. Vasil'ev EV, Rumiantsev PO, Saenko VA, Il'in AA, Poliakova EIu, Nemtsova MV, Zaletaev DV. Mol Biol (Mosk); 2004 Feb 05; 38(4):642-53. PubMed ID: 15456136 [Abstract] [Full Text] [Related]
29. Breakpoint characterization of the ret/PTC oncogene in human papillary thyroid carcinoma. Smanik PA, Furminger TL, Mazzaferri EL, Jhiang SM. Hum Mol Genet; 1995 Dec 05; 4(12):2313-8. PubMed ID: 8634704 [Abstract] [Full Text] [Related]
30. ret rearrangements in Japanese pediatric and adult papillary thyroid cancers. Motomura T, Nikiforov YE, Namba H, Ashizawa K, Nagataki S, Yamashita S, Fagin JA. Thyroid; 1998 Jun 05; 8(6):485-9. PubMed ID: 9669285 [Abstract] [Full Text] [Related]
31. Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomas. Nikiforova MN, Ciampi R, Salvatore G, Santoro M, Gandhi M, Knauf JA, Thomas GA, Jeremiah S, Bogdanova TI, Tronko MD, Fagin JA, Nikiforov YE. Cancer Lett; 2004 Jun 08; 209(1):1-6. PubMed ID: 15145515 [Abstract] [Full Text] [Related]
32. Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas. Jhiang SM, Sagartz JE, Tong Q, Parker-Thornburg J, Capen CC, Cho JY, Xing S, Ledent C. Endocrinology; 1996 Jan 08; 137(1):375-8. PubMed ID: 8536638 [Abstract] [Full Text] [Related]
35. High frequency of rearrangement of the RET protooncogene (RET/PTC) in Chinese papillary thyroid carcinomas. Lee CH, Hsu LS, Chi CW, Chen GD, Yang AH, Chen JY. J Clin Endocrinol Metab; 1998 May 08; 83(5):1629-32. PubMed ID: 9589668 [Abstract] [Full Text] [Related]
37. The ret/ptc1 oncogene is activated in familial adenomatous polyposis-associated thyroid papillary carcinomas. Cetta F, Chiappetta G, Melillo RM, Petracci M, Montalto G, Santoro M, Fusco A. J Clin Endocrinol Metab; 1998 Mar 08; 83(3):1003-6. PubMed ID: 9506763 [Abstract] [Full Text] [Related]
38. Ret/PTC activation in benign and malignant thyroid tumors arising in a population exposed to low-dose external-beam irradiation in childhood. Sadetzki S, Calderon-Margalit R, Modan B, Srivastava S, Tuttle RM. J Clin Endocrinol Metab; 2004 May 08; 89(5):2281-9. PubMed ID: 15126554 [Abstract] [Full Text] [Related]
39. Prevalences of Gs alpha, ras, p53 mutations and ret/PTC rearrangement in differentiated thyroid tumours in a Korean population. Park KY, Koh JM, Kim YI, Park HJ, Gong G, Hong SJ, Ahn IM. Clin Endocrinol (Oxf); 1998 Sep 08; 49(3):317-23. PubMed ID: 9861322 [Abstract] [Full Text] [Related]
40. Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice. Santoro M, Chiappetta G, Cerrato A, Salvatore D, Zhang L, Manzo G, Picone A, Portella G, Santelli G, Vecchio G, Fusco A. Oncogene; 1996 Apr 18; 12(8):1821-6. PubMed ID: 8622903 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]